US 10806716
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted A61KA61K31/136A61K31/352
Quick answer
US patent 10806716 (Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity) held by Auransa Inc. expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Auransa Inc.
- Grant date
- Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/136, A61K31/352, A61K31/353, A61K31/404